Quick Takeaways
- Niall O'Donnell has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $45,448,205.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Niall O'Donnell
- Location
- St. Louis, MO
- Summary
- The estimated net worth of Niall O'Donnell is at least $45,448,205 dollars as of 08 Jun 2023. Niall O'Donnell is the Director of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $45.45M.
- Signature
- /s/ Jennifer P. Lam, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Niall O'Donnell and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Mirum Pharmaceuticals, Inc. ($45,448,205).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Niall O'Donnell
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | Director | $45,448,205 | 11 Nov 2022 | ||
| OKUR | Reneo Pharmaceuticals, Inc. | Director | 06 Jun 2023 | |||
| SPRB | SPRUCE BIOSCIENCES, INC. | Director | 25 May 2023 |
Insider Transactions Reported by Niall O'Donnell:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.